Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2020New England Journal of MedicineOpen Access

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBin CaoShandong Provincial HospitalYWYeming WangAcademy of Medical SciencesDWDanning WenJinyintan Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cao et al. (2020) studied this question.

synapsesocial.com/papers/69da539b84371aa676a3d136https://doi.org/10.1056/nejmoa2001282
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection2019 · 167 citations
  2. 2Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020 · 21,246 citations
  3. 3Small molecules targeting severe acute respiratory syndrome human coronavirus2004 · 539 citations
  4. 4Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial2018 · 262 citations
  5. 5Combination Therapy with Lopinavir/Ritonavir, Ribavirin and Interferon-α for Middle East Respiratory Syndrome2015 · 197 citations